Related Experiment Video
Updated: Jan 7, 2026

09:16
Generation of Genetically Modified Organotypic Skin Cultures Using Devitalized Human Dermis
Published on: December 14, 2015
11.8K
Mimicking Darier Disease In Vitro: A Human Epidermal Organoid Approach.
Rishika Agarwal1,2, Erika Parente1,2, Simon M Müller2
1Department of Biomedicine, University Hospital and University of Basel, Basel, Switzerland.
Experimental Dermatology
|December 30, 2025
Summary
Darier disease (DD) is a rare skin condition. Researchers created a new human epidermal organoid model from patient cells to study DD's molecular causes and test new treatments.
Area of Science:
- Dermatology
- Genetics
- Cell Biology
Background:
- Darier disease (DD) is a rare genetic disorder linked to ATP2A2 gene mutations.
- Calcium dysregulation and poor keratinocyte adhesion are hallmarks of DD.
- Limited availability of disease models hinders understanding of DD's molecular mechanisms.
Purpose of the Study:
- To develop and validate a human epidermal organoid model for studying Darier disease.
- To investigate the molecular and phenotypic characteristics of DD using this novel model.
- To establish a platform for personalized drug screening in Darier disease.
Main Methods:
- Generation of human epidermal organoids from Darier disease patient keratinocytes.
- Analysis of acantholysis, desmosomal protein localization, and epidermal barrier function.
- Transcriptomic profiling to identify molecular pathways affected in DD organoids.
Main Results:
- The DD organoid model successfully recapitulated key pathological features of Darier disease, including acantholysis and desmosomal dysfunction.
- Mislocalization of desmosomal proteins was observed in the DD organoids.
- Transcriptomic analysis revealed significant perturbations in pathways related to epidermal development, cell adhesion, and keratinocyte differentiation.
Conclusions:
- Human epidermal organoids derived from DD patients represent a valuable and effective model for studying Darier disease.
- This model provides a unique platform for investigating the complex molecular pathology of DD.
- The developed organoid system holds promise for personalized drug screening and therapeutic development for Darier disease.

